Motherwort in Menstrual and Postpartum Tradition

Half of motherwort's name records a tradition of women's medicine that ran, in Europe, for well over a thousand years, and that still runs in East Asia under a different species. This page sets out that tradition carefully and respectfully — what the herb was given for, how it was prepared, who gave it, and what the two literatures say — and labels every claim at the tier the evidence actually supports, which for almost all of it is traditional use only.

Before any of that, one point has to come first, because the name works against it. Motherwort must be avoided in pregnancy. The word "motherwort" and the postpartum tradition together lead a great many people to assume the plant is safe for pregnant women. It is not what the tradition says and it is not what herbal safety references say. The herb was classed as a uterine stimulant and an emmenagogue — the very properties that made it valuable for bringing on a delayed period and for helping the womb contract after delivery are the properties that make it inappropriate during a pregnancy you intend to keep. This is one of the clearest examples on this site of a common name implying a safety profile it does not have.

Table of Contents

1. Pregnancy: The Contraindication the Name Hides
2. "Mother" and "Throw-wort": Reading the Names
3. The European Menstrual Tradition
4. The Postpartum Tradition
5. Yi Mu Cao: The Chinese Species
6. What "Emmenagogue" and "Uterine Stimulant" Mean
7. Chemistry Behind the Uterine Claims
8. What Modern Evidence Exists
9. Where the Calming Tradition Overlaps
10. Better-Evidenced Options for the Same Complaints
11. Cautions Specific to This Use
12. Evidence Tiers at a Glance
13. Key Research Papers
14. Connections

Pregnancy: The Contraindication the Name Hides

Almost every herb on this site can be discussed and then qualified. This one has to be qualified first.

The reasoning is straightforward and does not depend on modern research at all — it comes out of the tradition's own account of the plant. Motherwort was used to bring on a period that had not come, and to help the uterus contract down after a birth. Both are uterine-stimulant actions. A plant chosen because it can nudge the uterus into activity is not a plant to take while trying to maintain a pregnancy. Standard herbal safety references and European regulatory documentation both treat pregnancy as a contraindication, and the reason given is exactly this.

Two further points make the warning worth repeating rather than mentioning once.

The name actively misleads. "Motherwort" reads as a herb for mothers, and in a sense it was — for mothers in labour and after delivery, not during pregnancy. Add the fact that palpitations, breathlessness and anxiety are all common in pregnancy, and that motherwort is widely recommended online for exactly those symptoms, and you have a foreseeable path by which a pregnant woman takes a contraindicated uterine stimulant while trying to settle her heart. That path is the reason this section sits at the top of the page.

Breastfeeding is not established either. There is no meaningful safety data for motherwort during lactation, so the reasonable default is to avoid it. That includes the traditional postpartum use, which was practised in a world with a different risk calculus and no way to detect a problem in an infant.

If you are pregnant and have palpitations, breathlessness, anxiety, or a racing heart, those symptoms deserve assessment on their own merits — pregnancy changes cardiac physiology substantially and some presentations need attention. Talk to your midwife or doctor. See also Motherwort Safety: Cardiac Interactions and Pregnancy.

Back to Table of Contents

"Mother" and "Throw-wort": Reading the Names

The names are the primary source here, and they are unusually legible.

Wort is simply Old English for a plant — the same element as in St John's wort, soapwort and lungwort. Mother refers to the womb: in older English medical writing "the mother" was itself a term for the uterus, and "fits of the mother" described what would now be read as a mix of uterine and nervous complaints. Motherwort therefore meant, quite literally, the womb-herb. A secondary and gentler reading — that it eased an anxious mother's heart — circulated alongside the anatomical one, and both meanings are attested.

Throw-wort, an old English folk name, is generally read as referring to the "throws" or throes of labour, which makes it a second obstetric name for the same plant. Lion's tail and lion's ear describe the shaggy tapering flower spike and translate the Greek genus name Leonurus — leon plus oura. And the German Herzgespann, built on Herz (heart), belongs to the cardiac side of the plant's identity.

What the names collectively record is a plant with two long-standing jobs, obstetric and cardiac, which is unusual. Most herbs accumulate a scattered list of uses; motherwort's names converge on the same two, in multiple languages, over centuries. That is a genuine signal about how the plant was actually used. It is not a signal about whether it worked. Evidence tier: traditional use only.

Back to Table of Contents

The European Menstrual Tradition

European herbalism used motherwort across a set of menstrual complaints. The pattern is consistent enough across sources to describe with reasonable confidence.

Delayed or scanty periods

This is the classic emmenagogue use. Motherwort was given to encourage a period that had not arrived or that came scantily. It appears repeatedly in this role in the herbal literature, and it is the use that most directly generates the pregnancy contraindication — historically, "bringing on a delayed period" was sometimes a euphemism, and herbalists were aware of the overlap.

Menstrual cramps

Motherwort was used for cramping pain, generally described as helping a griping, tense, spasmodic pain rather than a dull ache. The traditional framing was antispasmodic — easing tension in the uterine muscle — often combined with the herb's calming effect on the person as a whole. Compare valerian, red raspberry leaf and yarrow, all used similarly in European practice.

Premenstrual tension and irritability

Here the two halves of the herb's reputation meet: the same calming action described in the nervous-heart tradition was applied to premenstrual irritability, restlessness and low mood. This is arguably the most internally consistent traditional use motherwort has, because it draws on the one action with any preclinical support.

Menopausal complaints

Motherwort appears in traditional and contemporary herbal practice for menopausal symptoms — particularly palpitations, anxiety, night sweats and difficulty settling. Palpitations and anxiety are genuinely common in perimenopause and are a frequent reason women arrive at this plant. Note carefully that motherwort is not a phytoestrogen and has no demonstrated hormonal action, so this use rests on the calming and cardiac traditions rather than on any hormonal mechanism. Herbs with actual trial data for menopausal symptoms are different plants — see black cohosh and sage — and the medical picture is covered under Perimenopause and Menopause.

All four of these are traditional use only. There are no controlled trials of Leonurus cardiaca for dysmenorrhoea, cycle regulation, premenstrual symptoms or menopausal complaints.

Back to Table of Contents

The Postpartum Tradition

The postpartum use is the one the plant's name most directly commemorates, and it had three distinct components.

Uterine involution. After delivery, the uterus must contract back down — a process that both closes off bleeding from the placental site and returns the organ toward its usual size. Motherwort was given to support those contractions. Modern obstetric practice pursues the same goal with uterotonic drugs where needed, and the underlying physiological logic of the traditional use is recognisable rather than fanciful.

Afterpains. The cramping contractions of the days following birth — often worse with each successive baby and worse during breastfeeding — were another target. Here the traditional framing is a little contradictory: the herb was credited both with encouraging contraction and with easing the pain of it. Traditional herbalism was comfortable with that; modern pharmacology would want to know which.

Postpartum mood and anxiety. Motherwort was given for the tearfulness, agitation, sleeplessness and low mood of the early weeks. This is the traditional use that intersects most seriously with modern care, and the intersection needs to be stated plainly: postpartum depression and postpartum anxiety are common, serious and treatable, and they are not appropriate targets for self-treatment with a herb. Postpartum psychosis is a medical emergency. If you are struggling after a birth, tell someone who can help — a midwife, health visitor, or doctor. See Postpartum Depression.

Two further modern cautions apply to the postpartum period specifically. First, breastfeeding safety is not established for motherwort, so the traditional postpartum use runs directly against current sensible practice for anyone nursing. Second, postpartum bleeding is a clinical matter, not a herbal one: heavy or increasing bleeding after birth needs urgent assessment, and the historical association of very large motherwort doses with uterine bleeding is a reason for caution rather than confidence. See Postpartum Hemorrhage.

Evidence tier for the entire postpartum tradition: traditional use only.

Back to Table of Contents

Yi Mu Cao: The Chinese Species

The gynaecological tradition is not only European, and the East Asian version is larger, better documented and attached to a different plant.

Leonurus japonicus is known in traditional Chinese medicine as yi mu cao — conventionally rendered "benefit-mother herb," which is the same idea as "motherwort" arrived at independently. It is a standard material in Chinese gynaecological practice, used for menstrual irregularity, painful periods, and postpartum recovery, and it is used at a scale that dwarfs European motherwort use. Preparations derived from it are widely employed in China in the postpartum setting.

Three things follow, and they matter for anyone reading claims about "motherwort."

1. Most of the pharmacology is japonicus, not cardiaca. If you encounter detailed molecular or animal work on uterine contraction, microcirculation or cardioprotection under the heading "motherwort," check the species. It is usually the Chinese plant.
2. Leonurine belongs mainly to japonicus. The alkaloid leonurine is the signature compound of the Chinese species and the subject of most of the interesting molecular research, including work on uterine smooth muscle and on cardiovascular protection. Its content in European L. cardiaca is low, variable, and has been genuinely disputed in the analytical literature. Supplement marketing routinely attributes leonurine pharmacology to European motherwort products; that attribution is not reliable.
3. The marker for cardiaca is stachydrine. The comparative quantification by Kuchta and colleagues in Fitoterapia in 2014, using quantitative nuclear magnetic resonance on both species, is the reference for this distinction.

None of this makes the Chinese literature irrelevant — it makes it about a different plant. Where a study is cited on this page, the species is named.

Back to Table of Contents

What "Emmenagogue" and "Uterine Stimulant" Mean

These two terms carry the whole safety argument, and they are worth unpacking because they are often used loosely.

An emmenagogue is a plant traditionally used to stimulate or promote menstrual flow. The category is historical rather than pharmacological: it groups plants by the effect their users attributed to them, and it includes plants whose actual mechanisms range from genuine uterine stimulation to hormonal effects to nothing measurable at all. Motherwort's membership in the category is well attested across sources.

A uterine stimulant (uterotonic) is something that increases uterine muscle tone or contraction. For motherwort this designation is traditional and inferential — drawn from how the plant was used and what it was believed to do — and it is supported for the genus in a general way by work on L. japonicus and uterine smooth muscle. For European L. cardiaca specifically, there is no controlled human data on uterine activity at all.

The important logical point is that the safety conclusion does not require the efficacy claim to be true. Even if motherwort does not reliably bring on a period, a plant traditionally selected for uterine stimulation, without human safety data in pregnancy, has no acceptable risk-benefit case during pregnancy. The absence of evidence cuts against use here, not in favour of it — the outcome being risked is a pregnancy.

Back to Table of Contents

Chemistry Behind the Uterine Claims

What is actually in the European plant, and what could plausibly act on the uterus?

• Stachydrine (proline betaine) — the consistently measurable alkaloid marker of L. cardiaca. It has been studied for cardiovascular and metabolic effects; a specific uterine action in humans has not been established.
• Leonurine — the alkaloid behind most uterine-relevant pharmacology in the genus, and chiefly a constituent of L. japonicus. This is the single most important species caveat on this page.
• Iridoid glycosides — characteristic of the genus; contribution to uterine effects unknown.
• Flavonoids — rutin, quercetin, hyperoside, quercitrin and relatives. A substantial fraction of the herb; several have antispasmodic activity in laboratory smooth-muscle preparations generally, which is a plausible but unproven route to the traditional antispasmodic use.
• Diterpene bitters — labdane-type diterpenes such as leocardin, characterised by Agnihotri and colleagues in Planta Medica in 2008, plus phenylethanoid glycosides including lavandulifolioside. These give the herb its severe bitterness, which is a practical obstacle to the traditional tea.

Notably absent: motherwort is not a phytoestrogen and has no established hormonal activity. It does not belong in the same category as red clover or soy isoflavones, and it should not be described as balancing hormones. Whatever it does, it does not appear to do it that way.

Back to Table of Contents

What Modern Evidence Exists

For the menstrual and postpartum uses of Leonurus cardiaca, the honest summary is short: there are no controlled clinical trials. Not for dysmenorrhoea, not for cycle regulation, not for premenstrual symptoms, not for menopausal complaints, not for postpartum involution or mood.

The two major reviews confirm this. Wojtyniak, Szymański and Matławska's review of the phytochemistry and pharmacology of Leonurus cardiaca in Phytotherapy Research in 2013 catalogues the traditional gynaecological indications and the absence of trials supporting them. Fierascu and colleagues' 2019 update in BioMed Research International, written against the European Medicines Agency's assessment of the herb, reaches the same position — which is precisely why Europe's regulatory status is traditional use, granted on documented history and acceptable safety rather than demonstrated efficacy. Note too that the European registered indication is for mild stress-related cardiac symptoms, not for gynaecological ones.

The only human study of any kind on L. cardiaca is the small open-label oil-extract report by Shikov and colleagues in Phytotherapy Research in 2011, in hypertension with anxiety and sleep disturbance. It was not a gynaecological study and says nothing about these uses.

On the japonicus side there is considerably more — laboratory and animal work on uterine smooth muscle, plus clinical literature from China on postpartum use, much of it published in Chinese-language journals of variable methodological quality and not readily assessable in the English literature. Describing that as evidence for European motherwort would be a species error. It is cited here as a search link so readers can see it for what it is.

Back to Table of Contents

Where the Calming Tradition Overlaps

One thread does run through both halves of motherwort's reputation, and it is the plant's most coherent claim.

Premenstrual irritability, perimenopausal anxiety and palpitations, and postpartum agitation are all states in which the nervous system is the dominant complaint. That is the one area where the plant has any preclinical support: the isolated glycoside lavandulifolioside from L. cardiaca produced sedative effects alongside reduced heart rate and blood pressure in animal testing (Miłkowska-Leyck and colleagues, Journal of Ethnopharmacology, 2002), and modified dry extracts of the herb showed psychotropic activity in animal behavioural testing (Koshovyi and colleagues, Plants, 2021).

So if there is a defensible modern reading of the "mother" tradition, it is not that motherwort regulates a cycle or contracts a uterus. It is that a mildly sedative bitter herb was being given to women in physiologically turbulent and emotionally demanding periods of life, and that some of what was observed was calming. That is a modest claim, it is preclinical, and it is discussed in full on Motherwort for Anxiety and Nervous Tension.

Perimenopausal palpitations deserve one specific note: they are extremely common, they are also a period of life in which cardiovascular risk rises, and they should not be assumed hormonal without assessment. If your palpitations have not been recorded, read the palpitations page and its red-flag list.

Back to Table of Contents

Better-Evidenced Options for the Same Complaints

If a specific complaint brought you here, other approaches have more behind them.

• Period pain. Non-steroidal anti-inflammatory drugs are genuinely effective for dysmenorrhoea and work through a well-understood prostaglandin mechanism; heat has small controlled trials behind it; hormonal contraception helps many. Background: Dysmenorrhea. Herbal options with more data than motherwort include dong quai and valerian.
• Premenstrual symptoms. Chasteberry has the largest trial literature of any herb used for premenstrual syndrome. For the severe form, Premenstrual Dysphoric Disorder has specific effective treatment.
• Irregular or absent periods. This needs a cause, not a remedy. Thyroid disease, polycystic ovary syndrome, low body weight, high stress load, and pregnancy itself all cause it, and the management differs completely between them.
• Menopausal symptoms. Black cohosh and sage have trial data; hormone therapy has by far the most. See Menopause and HRT.
• Postpartum mood. Effective treatment exists and matters. Postpartum Depression.

Saying this is not a dismissal of the herbal tradition. It is what an educational page owes a reader who came looking for help with a specific problem.

Back to Table of Contents

Cautions Specific to This Use

• Pregnancy — avoid. Traditional uterine stimulant and emmenagogue. This is the firm rule, and it is the one the name obscures.
• Trying to conceive — avoid. If a cycle might already be a very early pregnancy, an emmenagogue is the wrong thing to take.
• Breastfeeding — avoid. No meaningful safety data.
• Heavy menstrual bleeding — avoid. Very large doses have historically been associated with uterine bleeding, and the theoretical antiplatelet caution compounds the concern. Heavy bleeding also needs a diagnosis.
• Postpartum bleeding — medical, not herbal. Heavy or increasing bleeding after birth needs urgent care.
• On anticoagulants or antiplatelet drugs — theoretical additive bleeding risk.
• On cardiac, blood-pressure, or sedative medication — see the safety page.
• Digestive upset — the intense bitterness commonly produces nausea, stomach discomfort or loose stools, especially at higher doses. Handling the fresh plant can irritate sensitive skin.

Back to Table of Contents

Evidence Tiers at a Glance

• Traditional use only — delayed or scanty periods, menstrual cramps, premenstrual tension, menopausal palpitations and anxiety, postpartum uterine involution, afterpains, postpartum mood. Centuries of documented European use; no controlled trials for any of them.
• Traditional use only, different species — the yi mu cao (Leonurus japonicus) gynaecological tradition in Chinese medicine, with its own much larger literature that does not transfer to European L. cardiaca.
• Preclinical — sedative activity of lavandulifolioside and psychotropic activity of whole dry extracts of L. cardiaca in animals; laboratory and animal uterine smooth-muscle work largely on L. japonicus and leonurine.
• Preliminary human, uncontrolled — one small open-label study of L. cardiaca oil extract, in hypertension with anxiety and sleep disturbance, not gynaecological.
• Randomized clinical trial evidence — none for any menstrual, menopausal or postpartum indication.
• Safety — pregnancy contraindicated. Based on the traditional uterine-stimulant classification and the absence of human safety data. This is a firm recommendation, not a hedge.

Back to Table of Contents

Key Research Papers

Links are PubMed topic searches, so they return the live literature rather than a single record.

1. Wojtyniak K, Szymański M, Matławska I. Leonurus cardiaca L. (motherwort): a review of its phytochemistry and pharmacology. Phytotherapy Research, 2013. Catalogues the traditional gynaecological indications and the absence of trials. PubMed: Leonurus cardiaca review
2. Fierascu RC, Fierascu I, Ortan A, et al. Leonurus cardiaca L. as a source of bioactive compounds: an update of the European Medicines Agency assessment report. BioMed Research International, 2019. Sets chemistry and pharmacology against Europe's regulatory assessment, including the traditional-use basis. PubMed: Leonurus cardiaca EMA assessment update
3. Kuchta K, Ortwein J, Hennig L, et al. Direct quantification of stachydrine in Leonurus japonicus and L. cardiaca by quantitative nuclear magnetic resonance. Fitoterapia, 2014. The analytical basis for keeping the two species apart. PubMed: stachydrine in Leonurus species
4. Reviews of Leonurus japonicus (yi mu cao) traditional uses, phytochemistry and pharmacology. The gynaecological literature of the genus is overwhelmingly here. PubMed: Leonurus japonicus review
5. Research on leonurine and uterine smooth muscle, largely in Leonurus japonicus preparations and animal or tissue models. The mechanistic root of the uterine-stimulant classification. PubMed: leonurine uterine smooth muscle
6. Miłkowska-Leyck K, Filipek B, Strzelecka H. Pharmacological effects of lavandulifolioside from Leonurus cardiaca. Journal of Ethnopharmacology, 2002. Sedative activity plus reduced heart rate and blood pressure in animals — the one action with preclinical support. PubMed: lavandulifolioside Leonurus cardiaca
7. Koshovyi O, Raal A, Kireyev I, et al. Phytochemical and psychotropic research of motherwort (Leonurus cardiaca L.) modified dry extracts. Plants, 2021. Whole-extract animal behavioural testing. PubMed: Leonurus cardiaca psychotropic extracts
8. Shikov AN, Pozharitskaya ON, Makarov VG, et al. Effect of Leonurus cardiaca oil extract in patients with arterial hypertension accompanied by anxiety and sleep disorders. Phytotherapy Research, 2011. The only human study of the European species; not gynaecological. PubMed: Leonurus cardiaca oil extract study
9. Agnihotri VK, ElSohly HN, Smillie TJ, et al. New labdane diterpenes from Leonurus cardiaca. Planta Medica, 2008. The bitter diterpenes that make the traditional tea hard to take. PubMed: labdane diterpenes Leonurus cardiaca
10. Literature on herbal medicine use in pregnancy and its safety, including reviews of emmenagogue and uterine-stimulant herbs. The general framework behind the pregnancy contraindication. PubMed: herbal medicine safety in pregnancy
11. Literature on herbal medicine use during lactation and the absence of data for most botanicals. PubMed: herbal medicines and breastfeeding
12. Trial literature on herbal treatments for dysmenorrhoea and premenstrual syndrome — the fair benchmark against which motherwort's gynaecological evidence should be judged. PubMed: herbal medicine dysmenorrhoea trials
13. Broader current searches: PubMed: Leonurus cardiaca uterine and PubMed: motherwort postpartum.

External Resources

• NCBI Bookshelf — hosts LactMed, the US National Library of Medicine's drugs-and-lactation database, the standard reference for breastfeeding safety.
• MedlinePlus — consumer health information on menstrual, pregnancy and postpartum topics.
• NCCIH — US National Center for Complementary and Integrative Health; herb evidence summaries.
• European Medicines Agency — publishes the motherwort herbal monograph and assessment report, including the pregnancy position.
• NHS (United Kingdom) — plain-language guidance on periods, pregnancy and postpartum care.
• American College of Obstetricians and Gynecologists — professional guidance and patient information.

Back to Table of Contents

Connections

• All Herbs
• Motherwort
• Motherwort Benefits Hub
• Motherwort Safety
• Motherwort for Anxiety
• Motherwort for Palpitations
• Dysmenorrhea
• Menopause
• Perimenopause
• Menopause and HRT
• Postpartum Hemorrhage
• Postpartum Depression
• Premenstrual Dysphoric Disorder
• Dong Quai for Menstrual Health
• Chasteberry Benefits
• Black Cohosh for Menopause
• Red Raspberry Leaf
• Yarrow for Menstrual Use
• Valerian for Menstrual Cramps
• Reproductive Medicine

Safety Note and Disclaimer

This page is health education, not medical advice. Motherwort's menstrual and postpartum uses are traditional only — there are no controlled clinical trials of Leonurus cardiaca for period pain, cycle regulation, premenstrual or menopausal symptoms, or postpartum recovery. Most of the pharmacological research on the genus concerns the related Chinese species Leonurus japonicus and does not transfer. Motherwort must be avoided in pregnancy: it is a traditional uterine stimulant and emmenagogue, and its common name misleadingly suggests otherwise. It should also be avoided while trying to conceive and while breastfeeding, where safety data are lacking. Heavy menstrual bleeding, absent periods, and any bleeding after birth need medical assessment rather than a herb, and postpartum depression, anxiety and psychosis need prompt professional care. Speak with a qualified clinician before starting any herbal preparation, particularly if you take cardiac, sedative, antiplatelet or anticoagulant medication.

Back to Table of Contents